Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion

Document Viewer

Share this page:

Title

Subject

Description

EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2

Creator

U.S. Food and Drug Administration

Date Last Updated (Year-Month-Day)

2020-05-08

Citation

Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/137889/download

Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/137890/download

URL

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs

Click for External Resource*

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Files for download

Item Type:

Guide

Collection

Implement

Citation for this page

U.S. Food and Drug Administration, “Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion,” NETEC Resource Library, accessed October 16, 2021, https://repository.netecweb.org/items/show/1403.

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.